Q2 2026 Humana Inc Earnings Call Transcript
Key Points
- Humana Inc (HUM) is on track to meet its Investor Day commitments, including achieving a sustainable pretax margin of at least 3% by 2028.
- The company has made significant progress in its Stars program, with operational improvements outpacing historical growth rates in key metrics.
- Humana Inc (HUM) has successfully centralized operations, such as utilization management, leading to cost savings and improved service consistency.
- The company has announced a divestiture of its minority interest in Gentiva, valued at approximately $900 million, which will help fund recent acquisitions.
- Humana Inc (HUM) has been awarded a statewide Illinois Medicaid managed care contract, expanding its Medicaid platform.
- The company faces uncertainties in the Stars program due to unknown industry thresholds, which could impact future performance.
- Humana Inc (HUM) plans to exit certain plans in 2027, potentially impacting approximately 600,000 members, although efforts will be made to recapture some of this volume.
- The company anticipates high drug cost trends continuing into 2027, which could pressure margins.
- There is inherent uncertainty in the Medicare Advantage (MA) market, with membership size and composition affecting margin outcomes.
- The company is in a blackout period for Stars data, limiting its ability to provide updates until final results are released by CMS.
Good day and thank you for standing by. Welcome to Humana's second-quarter 2026 earnings conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.
I'd now like to hand the conference over to Lisa Stoner, Vice President of Investor Relations. Please go ahead.
Thank you and good morning. We will begin this morning with brief remarks from Jim Rechtin, Humana's President and Chief Executive Officer; and Chief Financial Officer, Celeste Mellet. Following these remarks, we will host a question-and-answer session with industry analysts.
Before we begin our discussion, I need to advise call participants of our cautionary statement. Certain of the matters discussed in this conference call are forward-looking and involve a number of risks and uncertainties. Actual results could differ materially. Investors are advised to read the detailed risk factors discussed in our latest Form 10-K, our other filings with the Securities and Exchange Commission,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
